Early Results Amaze for One-Time Dravet Syndrome Treatment

(MedPage Today) — ATLANTA — Young children with Dravet syndrome improved dramatically with a novel gene therapy, according to initial results from a phase I/II trial reported here.
Among three children followed for at least 7 months after…

Source link : https://www.medpagetoday.com/meetingcoverage/aes/118864

Author :

Publish date : 2025-12-05 20:53:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30	31

Early Results Amaze for One-Time Dravet Syndrome Treatment

SBRT vs Standard RT: Which Offers a QoL Edge in NSCLC?

Resurrecting a Global Killer: ACIP’s Hep B Vote

Related Posts

Resurrecting a Global Killer: ACIP’s Hep B Vote

SBRT vs Standard RT: Which Offers a QoL Edge in NSCLC?

Cardiologists on Board With FDA’s Proposed Food Package Labels

ACIP Backs ‘Shared Decision-Making’ on Hep B Vax Birth Dose

First CAR T-Cell Therapy for Marginal Zone Lymphoma Gets FDA Green Light

Large MRI Study Points to Sex and Age Differences in Knee Injuries

Resurrecting a Global Killer: ACIP’s Hep B Vote

Early Results Amaze for One-Time Dravet Syndrome Treatment

SBRT vs Standard RT: Which Offers a QoL Edge in NSCLC?

Cardiologists on Board With FDA’s Proposed Food Package Labels

ACIP Backs ‘Shared Decision-Making’ on Hep B Vax Birth Dose

First CAR T-Cell Therapy for Marginal Zone Lymphoma Gets FDA Green Light

Large MRI Study Points to Sex and Age Differences in Knee Injuries

Novel Drug Reduced Proteinuria by 46% in IgA Nephropathy Trial

Categories

Archives